Cognition/Performance
Semax
Synthetic nootropic peptide used for cognitive support and neurorecovery, primarily studied in Russia for cerebrovascular disorders.
Semax
Synthetic nootropic peptide used for cognitive support and neurorecovery, primarily studied in Russia for cerebrovascular disorders.
38
C
evidenceCaution
riskProven Benefits
01May improve cognitive function
02May aid stroke recovery
03May reduce mental fatigue
Chemical Forms
Recommended
- Nasal spray (acetate or amidate)
Avoid
- Oral capsules (poor peptide absorption)
- Unverified raw powder (sterility and dosing risks)
Expert Note
As a peptide, Semax is destroyed by gastric enzymes and has negligible oral bioavailability. Intranasal delivery bypasses first-pass metabolism and provides direct central nervous system uptake via the olfactory region. Injectable forms exist in research settings but require professional administration.
Protocol
Amount
300-600 mcg
Frequency
Once or twice daily
When
Morning or early afternoon; avoid late-day dosing due to potential alertness effects.
Condition-Based Dosing
Cognitive impairment or post-stroke recovery
600 mcg twice daily intranasally for 5-10 days
General nootropic use in healthy adults
300-600 mcg once daily intranasally
Safety & Limits
Upper Safe Limit
No established UL; clinical protocols have used up to 600 mcg twice daily short-term. Long-term safety data beyond several weeks is sparse.
Cycling
4-6 weeks on followed by 2-4 weeks off, based on Russian clinical practice and theoretical receptor adaptation.
Contraindications
Pregnancy or breastfeeding — no safety data
Active malignancy — melanocortin peptides may theoretically influence cell signaling
Severe uncontrolled hypertension — may affect cerebral circulation
Avoid Combining With
- ✕Alcohol (may blunt neurotrophic and cognitive effects)
- ✕Sedatives or hypnotics (theoretical antagonism of alertness effects)
Updated Invalid Date